| mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.099 |
0.05 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
| mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.05 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.05 |
| mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.05 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |